Volume 143, Issue 2, Pages 356-364.e1 (August 2012) Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid- Refractory Ulcerative Colitis Bruce E. Sands, William J. Sandborn, Tom J. Creed, Colin M. Dayan, Ashwin D. Dhanda, Gert A. Van Assche, Miloš Greguš, Ajit Sood, Gourdas Choudhuri, Mary Jean Stempien, Daniel Levitt, Christopher S. Probert Gastroenterology Volume 143, Issue 2, Pages 356-364.e1 (August 2012) DOI: 10.1053/j.gastro.2012.04.043 Copyright © 2012 AGA Institute Terms and Conditions
Figure 1 Study schema. Gastroenterology 2012 143, 356-364.e1DOI: (10.1053/j.gastro.2012.04.043) Copyright © 2012 AGA Institute Terms and Conditions
Figure 2 (A) The presence of anti-BSX antibody by percentage CD25 receptor saturation at week 8. (B) Subjects who failed to achieve clinical response at week 8 by peripheral lymphocyte CD25 receptor saturation. Gastroenterology 2012 143, 356-364.e1DOI: (10.1053/j.gastro.2012.04.043) Copyright © 2012 AGA Institute Terms and Conditions
CONSORT diagram. Gastroenterology 2012 143, 356-364.e1DOI: (10.1053/j.gastro.2012.04.043) Copyright © 2012 AGA Institute Terms and Conditions